Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer / Zekri, J., Mokhtar, M., Karim, S. M., Darwish, T., Al-Foheidi, M., Rizvi, A., Al-Rehaily, S., Mahrous, M., Mansour, M. (2015)
web address of the page http://jnas.nbuv.gov.ua/article/UJRN-0000409318
Experimental Oncology  А - 2020 /  Issue (2015, Vol. 37, № 2)
Zekri J., Mokhtar M., Karim S. M., Darwish T., Al-Foheidi M., Rizvi A., Al-Rehaily S., Mahrous M., Mansour M.
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
Cite:
Zekri, J., Mokhtar, M., Karim, S. M., Darwish, T., Al-Foheidi, M., Rizvi, A., Al-Rehaily, S., Mahrous, M., Mansour, M. (2015). Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer. Experimental Oncology, 37 (2), 146-150. http://jnas.nbuv.gov.ua/article/UJRN-0000409318 | |
|
|
PDF